Compare BCAB & CMBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BCAB | CMBM |
|---|---|---|
| Founded | 2007 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Radio And Television Broadcasting And Communications Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.6M | 65.5M |
| IPO Year | 2020 | 2019 |
| Metric | BCAB | CMBM |
|---|---|---|
| Price | $0.31 | $1.54 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $1.00 | N/A |
| AVG Volume (30 Days) | ★ 2.0M | 481.1K |
| Earning Date | 11-13-2025 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $172,215,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $18.01 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.24 | $0.23 |
| 52 Week High | $1.43 | $6.80 |
| Indicator | BCAB | CMBM |
|---|---|---|
| Relative Strength Index (RSI) | 26.50 | 46.03 |
| Support Level | $0.40 | $1.42 |
| Resistance Level | $0.82 | $1.68 |
| Average True Range (ATR) | 0.11 | 0.15 |
| MACD | -0.04 | 0.02 |
| Stochastic Oscillator | 0.19 | 48.58 |
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.